Z-0561-2021 Class II Terminated
FDA device recall Z-0561-2021 was initiated by Medtronic Heart Valves Division on Oct 23, 2020 and is designated Class II. Reason for recall: Potential for Transcatheter Aortic Valve (TAV) leaflet damage when performing a post-implant balloon dilatation (PID). The recall status is terminated (terminated Nov 22, 2022). Affected quantity: 19,961 units.
Recall details
- Product Type
- Devices
- Report Date
- Dec 16, 2020
- Initiation Date
- Oct 23, 2020
- Termination Date
- Nov 22, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19,961 units
Product description
Reason for recall
Distribution pattern
Worldwide distribution - U.S. Nationwide distribution and the countries of Panama, Denmark, Austria, Germany, Finland, Sweden, Colombia, India, Mexico, Brazil, Spain, United Kingdom, Australia, Ireland, Italy, Argentina, Japan, Poland, Russian Federation, Hungary, Kazakhstan, Luxembourg, Portugal, Norway, Egypt, Saudi Arabia.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0561-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026